Scientists from across the world who are
attending the International Congress of Immunology in Melbourne have learnt about
ground-breaking immunology research taking place at Hudson Institute of Medical
Research.
Around 20 delegates from 11
countries including USA,
Brazil, Iran, South Korea and Norway toured the
Monash Health Translation Precinct, including the $87.5 million Translational
Research Facility on Tuesday (August 23).
The visitors
ranged from undergraduate students to postdoctoral researchers and lab heads,
with diverse research interests in immunology, ranging from malaria to cancer
and vaccines.
Scientists from Hudson Institute and
School of Clinical Sciences at Monash Health presented on their breakthrough immunology
research into diseases including lung cancer, emphysema, neonatal diseases and
vasculitis.
Professor Brendan Jenkins, Head of
Hudson’s Centre for Innate Immunity and Infectious Diseases at Hudson
Institute, said the breadth of both the immunology research and facilities at
MHTP impressed visitors.
“The delegates that visited had wide-ranging research interests, ranging from cytokine
and cellular immunology, to cancer, and vaccines and the ageing immune system,”
Professor Jenkins said.
“We were able to present
a snapshot of the leading basic and translational research on the immune system
which is being undertaken at the MHTP site, which was very well received by the
visiting delegates”.
The tour
showcased immunology labs as well as the Clinical Trials Centre and platform
technologies floor of the Translational Research Facility.
More than 3800 scientists
are in Melbourne for the week-long International Congress of Immunology, the
largest global event in the field of immunology.
A number of Hudson
Institute scientists, A/Prof Ashley Mansell, Dr Michael Gantier, Dr Michelle Tate,
Dr Claudia Nold and Dr Ina Rudloff are presenting their research at ICI.
Engagement tours
have taken place at institutions across Melbourne, including the Burnet Institute, the Peter Doherty Institute for Infection
and Immunity, the Olivia Newton-John Cancer Research Institute, Peter MacCallum
Cancer Centre and the Walter and Eliza Hall Institute.

No comments:
Post a Comment